Finnegan attorneys Ningling Wang and Yieyie Yang will join the panel discussion "The U.S. Supreme Court Ruling on Amgen v. Sandoz and What Developers Need to Know" at the second annual China Pharma IP Summit, hosted by YIP Events. The program will take place at the DoubleTree by Hilton Pudong hotel in Shanghai, China. For more information, or to register, please see YIP Events' website.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.